Volume: 25

1. Pathogenesis of Transplant Glomerulopathy. Page:71—75
2. Treatment of Recurrent Nephrotic Syndrome after Transplantation. Page:76—80
3. Treatment of Posttransplantation Recurrent Glomerulonephritis: IgA Nephropathy, Membranous Nephropathy, Membranoproliferative Glomerulonephritis. Page:81—86
4. Liver Regeneration and Factors Influencing Liver Regeneration in Donors and Recipients of Adult Living Donor Liver Transplantation Using Right Lobe Graft. Page:87—94
5. Successful ABO Incompatible Adult Living Donor Liver Transplantation with New Simplified Protocol without Local Infusion Therapy and Splenectomy. Page:95—105
6. Analysis of the Potential Deceased Donors in the Neurosurgical Intensive Care Units of Korea. Page:106—112
7. Oral Ulceration an Overlooked Complication of Mycophenolate Mofetil in a Renal Transplant Recipient. Page:113—115
8. A Case of Late Mixed Acute Humoral and Cellular Rejection Successfully Treated with Rituximab, Plasmapheresis and IVIg. Page:116—122
9. Indication of Pediatric Liver Transplantation. Page:151—154
10. Transplantation Techniques Unique in Pediatric Liver Transplantation. Page:155—164
11. Issues on Long-term Management after Liver Transplantation in Children. Page:165—168
12. Predictive Value of Donor Specific Antibody Measured by Luminex Single Antigen Assay for Antibody Mediated Rejection after Kidney Transplantation. Page:169—175
13. Hepatic Arterial Complications after Liver Transplantation: A Single-Center Experience. Page:176—183
14. Outcomes of Early Liver Transplantation in a Hospital That Is Starting to Perform Liver Transplantation. Page:184—189
15. Successful Renal Transplantation in Patients with Polycystic Kidneys after Renal Contraction by Renal Artery Embolization: Report on 2 Cases. Page:190—195
16. Serongative Acute Hepatic Failure-associated Aplastic Anemia in Pediatric Liver Transplantation. Page:276—281
17. Clinical Significance of Protocol Biopsy Soon after Renal Transplantation. Page:264—269
18. The Characteristics and Treatment of Bone Loss after Liver Transplant. Page:249—256
19. Paranasal Aspergillosis in Patients Prior to Liver Transplantation. Page:245—248
20. The Characteristics and Treatment of Bone Loss after Liver Transplant. Page:249—256
21. Paranasal Aspergillosis in Patients Prior to Liver Transplantation. Page:245—248
22. Cardiovascular Diseases after Solid Organ Transplantation. Page:229—238
23. Post-transplantation Osteoporosis. Page:239—244
24. Simultaneous Liver, Kidney Transplantation: A Single Center Experience. Page:270—275
25. Serongative Acute Hepatic Failure-associated Aplastic Anemia in Pediatric Liver Transplantation. Page:276—281
26. Clinical Significance of Protocol Biopsy Soon after Renal Transplantation. Page:264—269
27. Simultaneous Liver, Kidney Transplantation: A Single Center Experience. Page:270—275
28. Impact of Early Positive Culture Results on the Short-term Outcomes of Liver Transplants. Page:257—263
29. Impact of Early Positive Culture Results on the Short-term Outcomes of Liver Transplants. Page:257—263
30. Post-transplantation Osteoporosis. Page:239—244
31. Cardiovascular Screening before Transplantation. Page:225—228
32. Cardiovascular Diseases after Solid Organ Transplantation. Page:229—238
33. Cardiovascular Screening before Transplantation. Page:225—228
34. The Changes of Graft Survival and Causes of Graft Failure after Kidney Transplantation. Page:22—30
35. Management of Posttransplantation Diabetes Mellitus (PTDM). Page:8—14
36. Optimal System for Deceased Organ Donation and Procurement in Korea. Page:1—7
37. Case of ABO-Incompatible Living Donor Kidney Transplantation without Blood Products in a Jehovah's Witness. Page:38—42
38. Effects of Antiplatelet Agents on the Graft Survival in Murine Cardiac and Skin Transplantation Model. Page:31—37
39. Artificial Liver Devices and Bioartificial Liver Systems: Current Status. Page:15—21